The menopause supplement market size is expected to see strong growth in the next few years. It will grow to $2.98 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to growing demand for personalized menopause nutrition, rising adoption of digital women’s health platforms, increasing focus on holistic and lifestyle-based menopause care, expansion of e-commerce supplement distribution, growing investment in female health research. Major trends in the forecast period include growing demand for natural hormone support solutions, rising adoption of non-hormonal supplement alternatives, expansion of symptom-specific menopause formulations, increased focus on women-centric wellness products, higher acceptance of preventive menopause care.
The increasing prevalence of menopausal symptoms is anticipated to drive the growth of the menopause supplement market in the coming years. Menopausal symptoms are the physical and emotional changes women undergo due to decreasing estrogen levels during the transition to menopause. This prevalence is rising as women live longer and spend a larger portion of their lives in the postmenopausal phase, resulting in prolonged exposure to hormonal and physical changes. Menopause supplements are commonly used to help manage these symptoms by supplying targeted nutrients and herbal compounds that may reduce hot flashes, mood swings, and sleep disturbances, promoting overall hormonal balance and well-being, although usage differs among individuals. For example, in December 2023, the National Library of Medicine, a U.S.-based government agency, reported that approximately 1.3 million women enter menopause each year, usually between ages 45 and 56, with 5% experiencing early menopause between 40 and 45 and 1% facing primary ovarian insufficiency before age 40. Thus, the rising prevalence of menopausal symptoms is a significant factor supporting growth in the menopause supplement market.
Major companies operating in the menopause supplement market are focusing on advanced innovations such as personalized supplements to deliver targeted symptom relief, improve effectiveness, and address the specific hormonal and nutritional requirements of individual women. Personalized supplements are customized nutritional formulations developed based on a person’s unique health needs, symptoms, hormones, or lifestyle factors. For example, in September 2025, Desert Harvest, a US-based company recognized for creating natural health solutions, launched its first menopause supplement containing human-identical lactoferrin. This innovation represents a notable advancement, as the lactoferrin closely resembles the form naturally present in the human body. The product is intended to support women during peri- and post-menopause by addressing concerns such as hormonal imbalance, fatigue, and immune health. By combining bioidentical lactoferrin with natural ingredients, the company aims to provide a non-hormonal, science-backed option for menopause relief. This launch also highlights Desert Harvest’s entry into the rapidly expanding women’s health and menopause supplement market.
In June 2025, Hims & Hers Health, Inc., a US-based health and wellness platform specializing in personalized healthcare, acquired ZAVA for an undisclosed amount. Through this acquisition, Hims & Hers aims to expand its European presence and utilize ZAVA’s established digital platform and medical expertise to provide personalized, high-quality healthcare across multiple markets. ZAVA, a UK-based company, focuses on offering tests for menopause and treatments for related symptoms.
Major companies operating in the menopause supplement market are Nestlé Health Science, Procter & Gamble, Bayer AG, Church & Dwight Co. Inc., Herbalife Nutrition Ltd., Amway Corporation, The Nature's Bounty Co., GNC Holdings Inc., Pharmavite LLC, Blackmores Limited, NOW Foods, Thorne HealthTech, Metagenics Inc., Jarrow Formulas Inc., Nature's Way, Vitabiotics Ltd., Standard Process Inc., Swisse Wellness Pty Ltd., Bio-Botanica Inc., Life Extension.
North America was the largest region in the menopause supplement market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the menopause supplement market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the menopause supplement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the menopause supplement market by increasing costs of imported botanical extracts, phytoestrogens, vitamins, minerals, and specialized formulation ingredients. North America and Europe are most affected due to reliance on imported nutraceutical raw materials, while Asia-Pacific faces cost pressure on supplement exports. These tariffs are contributing to higher product prices and margin pressure for manufacturers. However, they are also encouraging regional ingredient sourcing, local manufacturing expansion, and innovation in cost-efficient menopause supplement formulations.
The menopause supplement market research report is one of a series of new reports that provides menopause supplement market statistics, including menopause supplement industry global market size, regional shares, competitors with a menopause supplement market share, detailed menopause supplement market segments, market trends and opportunities, and any further data you may need to thrive in the menopause supplement industry. This menopause supplement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A menopause supplement is a dietary product formulated to support women undergoing hormonal changes during the menopausal transition by helping reduce common symptoms such as hot flashes, mood swings, and sleep disturbances. These supplements aid in maintaining hormonal balance and overall well-being. They are used to naturally improve quality of life during menopause without functioning as pharmaceutical hormone replacement therapy.
The main product types of the menopause supplement market include hormonal supplements, non-hormonal supplements, nutritional supplements, and others. Hormonal supplements are formulations containing bioidentical or synthetic hormones such as estrogen, progesterone, or combinations of these, designed to restore hormonal balance and relieve symptoms associated with menopause, including hot flashes, mood swings, and night sweats. These supplements are available in forms such as tablets, capsules, liquids, powders, gummies, and soft gels. The target genders include women and men (with related menopause-like conditions). The sales channels include store-based outlets, modern trade, hospital pharmacies, retail pharmacies, drug stores, and online pharmacies. The key end-users include hospitals, homecare, and clinics.
The menopause supplement market consists of sales of magnesium supplements, omega-3 fish oil capsules, herbal tea blends for menopause, collagen powder. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
Executive Summary
Menopause Supplement Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses menopause supplement market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for menopause supplement? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The menopause supplement market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Hormonal supplements; Non-hormonal supplements; Nutritional supplements; Other Product Types2) By Form: Tablets; Capsules; Liquids; Powders; Gummies; Soft gels
3) By Gender: Women; Men
4) By Sales Channel: Store-based; Modern trade; Hospital pharmacies; Retail pharmacies; Drug stores; Online pharmacies
5) By End-user: Hospitals; Homecare; Clinics
Subsegments:
1) By Hormonal Supplements: Estrogen Therapy; Progesterone Therapy; Combined Hormone Therapy; Bioidentical Hormone Therapy2) By Non-Hormonal Supplements: Herbal Extract Supplements; Phytoestrogen Supplements; Homeopathic Supplements; Botanical Blend Supplements
3) By Nutritional Supplements: Vitamin Supplements; Mineral Supplements; Protein Supplements; Omega Fatty Acid Supplements
4) By Other Product Types: Probiotic Supplements; Collagen Supplements; Antioxidant Supplements; Enzyme Supplements
Companies Mentioned: Nestlé Health Science; Procter & Gamble; Bayer AG; Church & Dwight Co. Inc.; Herbalife Nutrition Ltd.; Amway Corporation; The Nature's Bounty Co.; GNC Holdings Inc.; Pharmavite LLC; Blackmores Limited; NOW Foods; Thorne HealthTech; Metagenics Inc.; Jarrow Formulas Inc.; Nature's Way; Vitabiotics Ltd.; Standard Process Inc.; Swisse Wellness Pty Ltd.; Bio-Botanica Inc.; Life Extension
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Menopause Supplement market report include:- Nestlé Health Science
- Procter & Gamble
- Bayer AG
- Church & Dwight Co. Inc.
- Herbalife Nutrition Ltd.
- Amway Corporation
- The Nature's Bounty Co.
- GNC Holdings Inc.
- Pharmavite LLC
- Blackmores Limited
- NOW Foods
- Thorne HealthTech
- Metagenics Inc.
- Jarrow Formulas Inc.
- Nature's Way
- Vitabiotics Ltd.
- Standard Process Inc.
- Swisse Wellness Pty Ltd.
- Bio-Botanica Inc.
- Life Extension
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.21 Billion |
| Forecasted Market Value ( USD | $ 2.98 Billion |
| Compound Annual Growth Rate | 7.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |


